Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The constraints of antiretroviral uptake in rural areas: the case of Thamaga and surrounding villages, Botswana</title><author><name sortKey="Bene, Matlhogonolo" sort="Bene, Matlhogonolo" uniqKey="Bene M" first="Matlhogonolo" last="Bene">Matlhogonolo Bene</name><affiliation><nlm:aff id="AF1"></nlm:aff></affiliation></author><author><name sortKey="Darkoh, Michael B K" sort="Darkoh, Michael B K" uniqKey="Darkoh M" first="Michael B. K." last="Darkoh">Michael B. K. Darkoh</name><affiliation><nlm:aff id="AF2"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25365702</idno><idno type="pmc">4272138</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272138</idno><idno type="RBID">PMC:4272138</idno><idno type="doi">10.1080/17290376.2014.972057</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">002C56</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002C56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The constraints of antiretroviral uptake in rural areas: the case of Thamaga and surrounding villages, Botswana</title><author><name sortKey="Bene, Matlhogonolo" sort="Bene, Matlhogonolo" uniqKey="Bene M" first="Matlhogonolo" last="Bene">Matlhogonolo Bene</name><affiliation><nlm:aff id="AF1"></nlm:aff></affiliation></author><author><name sortKey="Darkoh, Michael B K" sort="Darkoh, Michael B K" uniqKey="Darkoh M" first="Michael B. K." last="Darkoh">Michael B. K. Darkoh</name><affiliation><nlm:aff id="AF2"></nlm:aff></affiliation></author></analytic><series><title level="j">Sahara J</title><idno type="ISSN">1729-0376</idno><idno type="eISSN">1813-4424</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Abstract</title><p>This article examines the constraints of antiretroviral (ARV) uptake in the villages of Thamaga, Kumakwane, Mankgodi and Gakgatla which are in the Kweneng District of Botswana. The social interactionist approach and theories of health behaviour provided the theoretical basis of the study. Data were obtained by using interviewer-administered questionnaires which were applied to a sample of 145 respondents and 61 people living with HIV/AIDS in the four villages. The results of the study showed that people aged 30–39 years represented the highest proportion of the persons on ARV treatment in the villages. Some of the people living with HIV believed that ARV therapy could better their lives during the initial stages of introduction, but with time, they lost hope and gave up the treatment. Culturally, parents and children in the villages do not discuss sexual matters at home and it was found in the study that there was little communication between parents and children on AIDS and ARV issues. Some churches in the area discouraged the use of ARV. There were also traditional doctors who made their patients mix traditional herbs treatment with ARV treatment. Distance, travel costs, cultural beliefs, stigma and discrimination among others were found to be important socio-economic factors inhibiting ARV uptake. Even though there were constraints on ARV uptake in the villages, efforts were being made by Government and non-governmental organizations to overcome them. The Ministry of Health provided information and education to the public using its strategy known as Information, Education and Communication. Nurses, doctors and chiefs taught people at kgotlas (traditional courts) in the villages about the dangers of the epidemic. Free HIV testing, ARVs and condoms were provided to the villagers. The outlook for ARV uptake looks generally promising for the future. However, if HIV/AIDS is to be contained, sexual behaviour of people in the villages needs to change.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Azjen, L" uniqKey="Azjen L">L. Azjen</name></author><author><name sortKey="Fishbein, M" uniqKey="Fishbein M">M. Fishbein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Creswell, J W" uniqKey="Creswell J">J. W. Creswell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dennis, K" uniqKey="Dennis K">K. Dennis</name></author><author><name sortKey="Wasai, L" uniqKey="Wasai L">L. Wasai</name></author><author><name sortKey="Ellen, S" uniqKey="Ellen S">S. Ellen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gatrell, A C" uniqKey="Gatrell A">A. C. Gatrell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gatrell, A C" uniqKey="Gatrell A">A. C. Gatrell</name></author><author><name sortKey="Elliott, S J" uniqKey="Elliott S">S. J. Elliott</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Jones, S P" uniqKey="Jones S">S. P. Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Libeon, C" uniqKey="Libeon C">C. Libeon</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Mosarwe, Q" uniqKey="Mosarwe Q">Q. Mosarwe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nam, L S" uniqKey="Nam L">L. S. Nam</name></author><author><name sortKey="Fielding, K" uniqKey="Fielding K">K. Fielding</name></author><author><name sortKey="Avalos, A" uniqKey="Avalos A">A. Avalos</name></author><author><name sortKey="Dickinson, D" uniqKey="Dickinson D">D. Dickinson</name></author><author><name sortKey="Gaolathe, T" uniqKey="Gaolathe T">T. Gaolathe</name></author><author><name sortKey="Geisler, P W" uniqKey="Geisler P">P. W. Geisler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ntata, P R T" uniqKey="Ntata P">P. R. T. Ntata</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Seleke, S F" uniqKey="Seleke S">S. F. Seleke</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stover, A S" uniqKey="Stover A">A. S. Stover</name></author><author><name sortKey="Dayton, D F" uniqKey="Dayton D">D. F. Dayton</name></author><author><name sortKey="Gabriel, S" uniqKey="Gabriel S">S. Gabriel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Taylor, B S" uniqKey="Taylor B">B. S. Taylor</name></author><author><name sortKey="Garduno, S L" uniqKey="Garduno S">S. L. Garduno</name></author><author><name sortKey="Reyes, E V" uniqKey="Reyes E">E. V. Reyes</name></author><author><name sortKey="Rojas, Y" uniqKey="Rojas Y">Y. Rojas</name></author><author><name sortKey="Vali O, R" uniqKey="Vali O R">R. Valiño</name></author><author><name sortKey="Donastorg, K" uniqKey="Donastorg K">K. Donastorg</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Vilili, G L" uniqKey="Vilili G">G. L. Vilili</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">SAHARA J</journal-id><journal-id journal-id-type="iso-abbrev">SAHARA J</journal-id><journal-id journal-id-type="archive">RSAH</journal-id><journal-id journal-id-type="publisher-id">rsah20</journal-id><journal-title-group><journal-title>Sahara J</journal-title></journal-title-group><issn pub-type="ppub">1729-0376</issn><issn pub-type="epub">1813-4424</issn><publisher><publisher-name>Routledge</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25365702</article-id><article-id pub-id-type="pmc">4272138</article-id><article-id pub-id-type="publisher-id">972057</article-id><article-id pub-id-type="doi">10.1080/17290376.2014.972057</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>The constraints of antiretroviral uptake in rural areas: the case of Thamaga and surrounding villages, Botswana</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bene</surname><given-names>Matlhogonolo</given-names></name><xref ref-type="aff" rid="AF1"><sup>a</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref><xref ref-type="corresp" rid="cor2"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Darkoh</surname><given-names>Michael B.K.</given-names></name><xref ref-type="aff" rid="AF2"><sup>b</sup></xref><xref ref-type="corresp" rid="cor3"><sup>*</sup></xref></contrib><aff id="AF1"><label><sup>a</sup></label><institution><named-content content-type="department">BA Environmental Science, MA Geography, is affiliated to the Department of Environmental Science</named-content>,<named-content content-type="institution-name">University of Botswana</named-content></institution>, Private Bag 708,<named-content content-type="city">Gaborone</named-content>,<country>Botswana</country></aff><aff id="AF2"><label><sup>b</sup></label><institution><named-content content-type="department">Professor of Environmental Science, is affiliated to the Department of Environmental Science</named-content>,<named-content content-type="institution-name">University of Botswana</named-content></institution>, Private Bag 708,<named-content content-type="city">Gaborone</named-content>,<country>Botswana</country></aff></contrib-group><author-notes><corresp id="cor1"><label>* </label>Email: <email xlink:href="matlhobene@yahoo.com">matlhobene@yahoo.com</email></corresp><corresp id="cor2">Email: <email xlink:href="mbene1@binghamton.edu">mbene1@binghamton.edu</email></corresp><corresp id="cor3"><label>* </label>Email: <email xlink:href="Darkohmb@mopipi.ub.bw">Darkohmb@mopipi.ub.bw</email></corresp></author-notes><pub-date pub-type="ppub"><day>2</day><month>1</month><year>2014</year><pmc-comment>string-date: December 2014</pmc-comment>
</pub-date><pub-date pub-type="epub"><day>3</day><month>11</month><year>2014</year></pub-date><volume>11</volume><issue>1</issue><fpage seq="19">167</fpage><lpage>177</lpage><permissions><copyright-statement>© 2014 The Author(s). Published by Taylor & Francis.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="rsah-11-167.pdf"></self-uri><abstract><title>Abstract</title><p>This article examines the constraints of antiretroviral (ARV) uptake in the villages of Thamaga, Kumakwane, Mankgodi and Gakgatla which are in the Kweneng District of Botswana. The social interactionist approach and theories of health behaviour provided the theoretical basis of the study. Data were obtained by using interviewer-administered questionnaires which were applied to a sample of 145 respondents and 61 people living with HIV/AIDS in the four villages. The results of the study showed that people aged 30–39 years represented the highest proportion of the persons on ARV treatment in the villages. Some of the people living with HIV believed that ARV therapy could better their lives during the initial stages of introduction, but with time, they lost hope and gave up the treatment. Culturally, parents and children in the villages do not discuss sexual matters at home and it was found in the study that there was little communication between parents and children on AIDS and ARV issues. Some churches in the area discouraged the use of ARV. There were also traditional doctors who made their patients mix traditional herbs treatment with ARV treatment. Distance, travel costs, cultural beliefs, stigma and discrimination among others were found to be important socio-economic factors inhibiting ARV uptake. Even though there were constraints on ARV uptake in the villages, efforts were being made by Government and non-governmental organizations to overcome them. The Ministry of Health provided information and education to the public using its strategy known as Information, Education and Communication. Nurses, doctors and chiefs taught people at kgotlas (traditional courts) in the villages about the dangers of the epidemic. Free HIV testing, ARVs and condoms were provided to the villagers. The outlook for ARV uptake looks generally promising for the future. However, if HIV/AIDS is to be contained, sexual behaviour of people in the villages needs to change.</p></abstract><trans-abstract xml:lang="fr"><title>Résumé</title><p>Cet article examine les contraintes liées à la prise des ARV dans les villages de Thamaga, Kumakwane, Mankgodi et Gakgatla dans le district de Kweneng au Botswana. L'approche interactionniste et les théories sur le comportement face à la santé ont constituées la base théorique de cette étude. Les données ont été récoltées au moyen de questionnaires administrés par l'enquêteur appliqués à un échantillon de 145 répondants et 61 personnes vivant avec le VIH/SIDA dans les quatre villages. Les résultats de l’étude montrent que les personnes âgées de 30 à 39 ans représentent le plus grand nombre de personnes sous traitement antirétroviral (ARV) dans les villages. Certaines des personnes vivant avec le VIH croyaient que la thérapie ARV pourrait améliorer leur vie pendant les phases initiales de son utilisation mais avec le temps, ils ont perdu espoir et ont abandonné le traitement. Sur le plan culturel, les parents ne discutent pas des questions sexuelles avec les enfants à la maison et l’étude à révélé qu'il y avait peu de communication entre les parents et les enfants sur les questions du SIDA et les ARV. Certaines églises de la région décourageaient l'utilisation des ARV. D'autre part, des médecins traditionnels ont fait prendre aux patients un traitement à bases d'herbes traditionnelles en même temps que le traitement ARV. La distance, les frais de voyage, les croyances culturelles, la stigmatisation et la discrimination se sont révélés être des facteurs socio-économiques importants entravant la prise des ARV. Malgré ces contraintes liées à la prise des ARV dans les villages, le gouvernement et les ONG déploient de nombreux efforts pour les surmonter. Le ministère de la Santé informe et éduque à travers sa stratégie Information, Éducation et Communication (IEC). Dans les <italic>kgotlas</italic> (cour traditionnelle) des villages, les infirmiers, les médecins et les chefs informent la population des dangers de l’épidémie. Le dépistage du VIH, les ARV et les préservatifs sont fournis gratuitement aux personnes dans les villages. De façon générale, les perspectives de la prise des ARV semblent prometteuses pour l'avenir. Cependant, si le VIH/SIDA doit être maitrisé, le comportement sexuel des personnes dans les villages doit changer.</p></trans-abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>rural areas</kwd><kwd>HIV/AIDS</kwd><kwd>ARV uptake</kwd><kwd>Masa programme</kwd></kwd-group><kwd-group kwd-group-type="author" xml:lang="fr"><title>Mots clés</title><kwd>Zones rurales</kwd><kwd>VIH/SIDA</kwd><kwd>prise des ARV</kwd><kwd>programme Masa</kwd></kwd-group><counts><fig-count count="5"></fig-count><table-count count="8"></table-count><equation-count count="0"></equation-count><ref-count count="22"></ref-count><page-count count="11"></page-count></counts></article-meta></front><body><sec sec-type="intro" id="S001"><title>Introduction</title><p>Since it was first discovered over 30 years ago, HIV has become one of the most devastating epidemics, taking the lives of 30 million people around the world (One International <xref rid="CIT0017" ref-type="bibr">2011</xref>). It is estimated that globally, in 2010 alone, HIV/AIDS killed 1.8 million people, of whom about 67% (1.2 million) were living in Sub Saharan Africa (ibid). The HIV/AIDS epidemic has already reversed many of the development gains made in Central, Eastern and Southern Africa over the past three decades (UNDP <xref rid="CIT0021" ref-type="bibr">1997</xref>). Though life-saving antiretroviral (ARV) treatment is available, access is not yet widespread in many countries of Sub Saharan Africa. By 2010, more than 6.6 million people were on life-saving ARV treatment of whom more than 5 million were living in Sub Saharan Africa (One International <xref rid="CIT0017" ref-type="bibr">2011</xref>). Even more worrying, new HIV infections have continued to outpace those added onto ARV treatment (One International <xref rid="CIT0017" ref-type="bibr">2011</xref>).</p><p>Botswana has one of the highest HIV infection rates in the world, with a general population prevalence of 19.8% in women and 13.9% in men (Ministry of Health [MOH] <xref rid="CIT0009" ref-type="bibr">2004</xref>). More alarming, infection rates are much higher in vulnerable groups such as pregnant women, at 32.4% (Government of Botswana <xref rid="CIT0006" ref-type="bibr">2006</xref>) and men on separation in marriage, at almost 70% (Mosarwe <xref rid="CIT0014" ref-type="bibr">2014</xref>). The government of Botswana, confronted by this major national crisis, decided to explore the feasibility of making ARV therapy available nationally. It forged a public–private partnership in July 2000 with the African Comprehensive HIV/AIDS Partnerships (ACHAP), an non-governmental organization (NGO) formed by the Bill & Melinda Gates Foundation and The Merck Company Foundation/Merck & Co., Inc to combat the scourge (MOH <xref rid="CIT0010" ref-type="bibr">2005</xref>). As part of this partnership, both Bill and Melinda Gates and the Merck Company Foundation contributed US$50 million each, while Merck & Co., Inc., pledged to donate two types of ARV medicines free of charge for the duration of the partnership (MOH <xref rid="CIT0010" ref-type="bibr">2005</xref>). Out of this partnership was born the ‘Masa programme', which is the brand name for the national ARV programme. As the first African country to implement a full-scale national ARV programme, Botswana has become a beacon of hope for the rest of the continent suffering from AIDS. The name of the national ARV Programme, ‘Masa', which means ‘new Dawn' in Setswana, ‘signifies the hope that ARVs offer to people living with HIV and AIDS, which includes the hope to live longer, healthier lives by providing them with time to nurture their families and build a future for the nation' (Government of Botswana <xref rid="CIT0006" ref-type="bibr">2006</xref>:3).</p><p>The overall goal of the Masa programme was to enhance prevention efforts and reduce the impact of HIV/AIDS on the people of Botswana through the introduction and effective utilization of ARV therapy. The objectives of the programme were to (Government of Botswana <xref rid="CIT0006" ref-type="bibr">2006</xref>):
<list list-type="bullet"><list-item><p>Mobilize communities to support treatment and care of HIV infected individuals.</p></list-item><list-item><p>Build capacity, both human resource and infrastructure, necessary for the successful implementation of the programme.</p></list-item><list-item><p>Provide highly active antiretroviral therapy (HAART) to eligible individuals.</p></list-item><list-item><p>Advise on and implement systems and policies to support the ARV therapy programme.</p></list-item><list-item><p>Guide/coordinate all efforts in the country geared towards implementation of the ARV programme.</p></list-item><list-item><p>Monitor and evaluate the programme to ensure continuous improvement of quality and effectiveness.</p></list-item></list></p><p>Provision of free treatment was built around an ‘ART site’ model, consisting of a hospital supported by satellite screening clinics. From January 2002 onwards, ARV therapy (ART) sites had been rolled out in a phased manner and 32 ART sites and 178 satellite clinics across the country were dispensing ARVs by the end of June 2010. Botswana Public Officers Medical Aid Scheme, Pula, Botswana Medical Aid Society and Private Medical Care and Workplace programmes have been monitoring and reporting on ARV use quarterly for the private sector, while Associated Fund Administrators has been responsible for outsourced clients (Ministry of Health [MOH] <xref rid="CIT0011" ref-type="bibr">2008</xref>). <xref rid="F0001" ref-type="fig">Fig. 1</xref> shows the ARV sites in Botswana.
<fig id="F0001" orientation="portrait" position="float"><label>Fig. 1. </label><caption><p>ARV sites in Botswana.</p></caption><graphic xlink:href="rsah-11-167-g001"></graphic></fig></p><p>From an initial rollout to the major sites at Gaborone, Serowe and Maun, the National ARV Programme has expanded and by January 2008, all 29 Public hospitals and over 60 local clinics in the country had been equipped with ARV facilities. In 2008, out of an estimated 130,000 people eligible for treatment, over 100,000 people had been put on life-saving ART across the nation (Ministry of Health [MOH] <xref rid="CIT0011" ref-type="bibr">2008</xref>). By the end of June 2010, a total of 123,474 infected people were on treatment in the public sector in the country, of whom 61.5% were females, 31.9% males and 6.6% children (MOH <xref rid="CIT0011" ref-type="bibr">2008</xref>). A further 15,412 were treated by the private sector under the Government's Out-sourcing Programme and 12,809 other people on ARVs were being treated in the private sector of the country by the Medical Aid Schemes and Work-place Programmes. This gives a total of 151,695 people currently receiving HAART in Botswana. This accounts for 92.6% of the projected total of 163,872 adults and children in need of ART at the end of June 2010 (MOH <xref rid="CIT0013" ref-type="bibr">2010</xref>). Since the inception of ARV in the country, a cumulative total of 16,016 people on ARVs had died while on HAART (MOH <xref rid="CIT0011" ref-type="bibr">2008</xref>).</p><p>Even though steps are being taken by the government and international agencies to curb the escalating HIV/AIDS epidemic in the country, through free provision of ARVs and information on assessing and reducing the risk of infection, the epidemic is still spreading in Thamaga and its surrounding villages as it is in other parts of the country and people are dying. The main motivation for this article is to find out what are the major socio-cultural constraints to ARV uptake which is leading to the continuing demise of people. This article therefore examines the major factors inhibiting ARV uptake in the villages. The general hypothesis is that sociocultural factors are constraining ARV uptake in the villages. The sociocultural factors examined include public attitude towards HIV patients on ARV, religion, cultural beliefs, stigma and discrimination, child–parent dialogue and distance travelled to acquire ARVs.</p></sec><sec id="S002"><title>Theoretical basis and literature review</title><sec id="S002-S2001"><title>Theoretical basis</title><p>Two theoretical approaches underpinned this study. These were the theories of health behaviour and the social interactionist/humanist approaches. Theories of health behaviour were used to explore the villagers' behaviour towards ARV treatment. Two main models of health behaviour were used. These were the health belief model and the theory of reasoned action. The health belief model is based on the understanding that a person will take a health-related action if the person feels that a health condition can be avoided, has a positive expectation that by taking a recommended action, he/she will avoid a negative health condition and believes that he/she can successfully take a recommended health action (Gatrell <xref rid="CIT0004" ref-type="bibr">2002</xref>; Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>). The model attempts to explain and predict health behaviours by focusing on the attitudes and beliefs of individuals, particularly with respect to their perceived susceptibility, seriousness and severity of the disease, benefit of service and barriers to accessing health care (Azjen & Fishbein <xref rid="CIT0001" ref-type="bibr">1980</xref>). This theory guided the design of the questionnaire and the analysis of the findings.</p><p>The theory of reasoned action says that a person's behaviour is determined by his/her attitude, the outcome of that behaviour and by the opinions of the person's social environment (Azjen & Fishbein <xref rid="CIT0001" ref-type="bibr">1980</xref>). The theory defines an attitude as a person's innate belief about whether the outcome of his/her action will be positive or negative while subjective norms are beliefs about what others would think about the behaviour. The theory of reasoned action was used to assess whether ARV was regarded as a social norm by the villagers or not and to determine their attitude towards ARV therapy. It was also used in the study to understand the underlying structures in the village community which hasten or hinder individuals seeking medical help in various health facilities when they fall sick.</p><p>The social interactionist/humanist approach places emphasis on the meaning of an illness or disease to an individual and understanding and meanings that make it rational to act in a particular way. The approach believes that if people do not see the severity in a particular disease, they may not be bothered to seek treatment (Gatrell <xref rid="CIT0004" ref-type="bibr">2002</xref>; Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>). Social interactionist approaches study individuals, small numbers of people, small communities such as villages or neighbourhoods rather than studying large areas. This is because the experience of place is more important than the accurate recordings of large numbers of locations (Gatrell <xref rid="CIT0004" ref-type="bibr">2002</xref>; Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>). The methods used are essentially qualitative rather than quantitative and the ultimate goal is empathic understanding and explanation rooted in the social, rather than the natural world (Gatrell <xref rid="CIT0004" ref-type="bibr">2002</xref>). The social interactionist approach was used in this research to understand what ARV therapy means to the infected people and the villagers in general.</p></sec></sec><sec id="S003"><title>Literature review</title><p>Few studies are available on ARV uptake in Africa. This section of the paper reviews the relevant literature on ARV uptake with special reference to Southern Africa, including Botswana.</p><p>A study on equity and access to ARV drugs in Malawi was conducted using a qualitative methodology (Ntata <xref rid="CIT0016" ref-type="bibr">2007</xref>). Interviews for the study covered all the three regions of Malawi. The study found that information benefited only people who were physically and socially nearer to ARV administration points. Physically, those in remote areas were disadvantaged as there were no newspapers and radios. Socially, information was accessible to those who were educated. Health services in Malawi were not evenly distributed and mostly concentrated in urban areas. For the poor and those living far away from Voluntary Counseling and Testing Centers and ARV clinics, availability and affordability of transport were key issues with regard to accessing the services. The study found that people were failing to travel to the district or central hospitals for ART initiation which required at least two visits.</p><p>Another major study on Malawi (Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>) dealt with the geographical analysis of ARV uptake. The study concentrated on the uptake among the youth in Lilongwe. Based on a sample of 1206 infected youth aged 15–24 who were on ART in Lilongwe Rural and Urban, the study analysed the proportion of the youth on ARV treatment, the openness about HIV status and ARV treatment, distance travelled to acquire ARV treatment and the perceptions of the youth. The study found that only 8.8% of the sample was on ARV treatment and 43% disclosed their HIV status to their family members. The youth had problems in discussing their status with friends, church leaders and teachers. The study noted that while those in Lilongwe Urban travelled shorter distances of 2–5 km, those infected in Lilongwe Rural had to travel more than 5–6 kms for ARV treatment. It also found that in several cases, the youth were prevented by social stigma from accessing ARV treatment. This last point corroborates with the finding of the study outlined above (Ntata <xref rid="CIT0016" ref-type="bibr">2007</xref>) which also noted that revealing one's status in Malawi could be risky and costly especially for women since men could force their wives to leave the house if they were found to be HIV-positive.</p><p>A study on the challenges of ART treatment in Tanzania noted that perceptions about ARVs varied among users (Dennis, Wasai & Ellen <xref rid="CIT0003" ref-type="bibr">2007</xref>). Some of the respondents in the study indicated that ARVs had significant side effects, while others said that ARVs were helpful in ameliorating the disease in the body. Several infected men believed that if they stopped the medication, their bodies would go weak, while most of the women indicated that, taking ARVs, kept the virus at bay and lengthened the user's life (Libeon <xref rid="CIT0008" ref-type="bibr">2007</xref>).</p><p>In a study cited by Vilili (<xref rid="CIT0022" ref-type="bibr">2008</xref>) on the experiences of ARV uptake in the provinces of Kwa-Zulu Natal and Limpopo, South Africa, the main factor found was stigma which prevailed in the HIV/AIDS care, treatment and even prevention. People living with AIDS at both household and community levels were reported to have difficulties in disclosing their status in fear of discrimination. Disclosure of status was often linked to the advanced stages of AIDS, that is, most people disclosed their status just before death.</p><p>Before the introduction of ARV therapy in 2002 in the national healthcare system, the Information, Education and Communication (IEC) environment in Botswana was largely based upon community outreach and mass media, promoting HIV/AIDS awareness and prevention messaging. Over the years, several surveys had been conducted to measure the efficiency of these campaigns. Most of the results had showed that there was a high level of awareness of HIV/AIDS within the communities. However, the Ministry of Health (MOH) found that the steady increase in HIV prevalence in Botswana during that period indicated that people were not translating knowledge and awareness about HIV/AIDS into changing behaviours (MOH <xref rid="CIT0010" ref-type="bibr">2005</xref>).</p><p>An article on the challenges of ARV treatment in Botswana indicated that out of 950 people on ARV treatment in the Kgalagadi district, about half resided in remote villages outside the district headquarters, Tsabong, where ARVs were dispensed (Seleke <xref rid="CIT0018" ref-type="bibr">2008</xref>). After realizing that many people in these areas were unemployed with little or no income and no transportation, district officials pushed for the rollout of treatment to satellite clinics (ibid). The factors that affected the ARV uptake which were identified included distance and transport costs.</p><p>The site location of clinics is an important role in access of ARVs (Jones <xref rid="CIT0007" ref-type="bibr">2012</xref>). Patients who stayed far and in remote areas sometimes skipped the medication as well as monthly appointments because they could not afford transport costs. The same trend was found in a study in Botswana where about 13% of patients indicated that travel or migration were the main reasons for missed medical appointments and pill doses (Taylor, Garduno, Reyes, Rojas, Donastorg, Brudney, <italic>et al</italic>. <xref rid="CIT0020" ref-type="bibr">2011</xref>).</p><p>In another study on ARV uptake in Botswana (Nam, Fielding, Avalos, Dickinson, Gaolathe & Geisler <xref rid="CIT0015" ref-type="bibr">2008</xref>), it was found that the principal barriers to ARV adherence included financial constraints (44%,) stigma (15%,) travel/migration (10%) and side effects (9%). If costs were removed as a barrier, adherence was predicted to increase from 54% to 74% (Nam <italic>et al</italic>. <xref rid="CIT0015" ref-type="bibr">2008</xref>). The study was done at the national level and did not indicate what was happening at the rural level. The other drawback was that the study focused only on the youth.</p><p>From the foregoing, much of the available literature on ARV uptake is topical and pitched at the macro scale of spatial analysis, that is, at the national level. Studies which analyse ARV uptake at local and community levels are few. To date, in Botswana, there are no outstanding studies on ARV uptake at the rural or village level. It is hoped that the findings of this study will contribute to fill the current gap in the literature.</p></sec><sec sec-type="methods" id="S004"><title>Methods</title><p>The study is descriptive and used a mixed-method approach to collect and analyse data in order to understand ARV uptake in the villages. Both qualitative and quantitative methods were used in the study.</p><sec id="S004-S2001"><title>Qualitative and quantitative approaches</title><p>The use of the descriptive qualitative approach is in line with the humanist/social interactionist approach which emphasizes getting the meaning of the illness or disease rather than the magnitude of the situation (Gatrell <xref rid="CIT0004" ref-type="bibr">2002</xref>; Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>). In conducting the study, qualitative methods were largely used in order to uncover and interpret the meaning of the illness which makes it ‘rational’ for patients to act in a particular way (Gatrell & Elliot <xref rid="CIT0005" ref-type="bibr">2009</xref>:84). According to Creswell (<xref rid="CIT0002" ref-type="bibr">1994</xref>), people are interested in meaning, how people make sense of their lives. The study used in-depth interview guide to get the qualitative data from the clients.</p><p>However, in order to get the magnitude of the issues being discussed, quantitative methods in the form of descriptive statistics such as Chi square and ANOVA were used to complement the findings. The mixing of both qualitative and quantitative methods, as Gatrell and Eliot (<xref rid="CIT0005" ref-type="bibr">2009</xref>:84) note, has proved singularly useful, with insights from in-depth interviews adding colour and explanatory power to the quantitative to shed light on the research questions.</p></sec><sec id="S004-S2002"><title>Sampling</title><p>Preceding the determination of sample size, a pilot reconnaissance survey was carried out with the assistance of health workers in Thamaga hospital and clinics in the area, to select the villages to be included in the sample. Three villages were selected in addition to Thamaga for the field study. These villages were Mankgodi, Kumakwane and Gakgatla (<xref rid="F0002" ref-type="fig">Fig. 2</xref>).
<fig id="F0002" orientation="portrait" position="float"><label>Fig. 2. </label><caption><p>Study area.</p></caption><graphic xlink:href="rsah-11-167-g002"></graphic></fig></p><p>To calculate the sample size, the following formula was used: <bold>n = N/1 + N (e)<sup>2</sup>,</bold> whereby <bold>n</bold> equals sample size, <bold>N</bold> equals number of households and <bold>e</bold> equals marginal error. Altogether, 145 respondents (95% confidence level, 5% error) were selected and interviewed. Stratified random sampling was used to select respondents from the four villages.</p><sec id="S004-S2002-S3001"><title>Purposive sampling</title><p>In order to gain further insights into the disease and patients' experience and constraints of ARV uptake, purposive sampling was used to select 61 patients out of a total of 3572 people in the four villages living with HIV. These 61 patients were the only ones who agreed to partake in the exercise. The researchers administered in-depth interviews to these patients. During data collection, the researchers used a tape recorder and note-taking so that all information given by the clients was captured. Both structured and semi-structured questions were used in the individual interview guide.</p></sec><sec id="S004-S2002-S3002"><title>Ethical consideration</title><p>Before the field data collection, ethical permit was sought and obtained from the Institutional Review Board, an organization in the MOH, Botswana, which deals with ethical matters. Informed consent was sought from the clients. Clients were made clear that participation was entirely voluntary and that they were free to withdraw from the study at any point in time.</p></sec><sec id="S004-S2002-S3003"><title>Data collection</title><p>Quantitative data collection took 6 months, from July to December 2010. Interviewer-administered questionnaires were the main tools used in collecting primary data. These data were obtained from three main sources which were the general public or residents of Thamaga and surrounding villages, people who were HIV-positive and on ARVs and key informants. The interviews were conducted face to face. Interviews with the general public were carried out in order to gain an understanding of local residents' attitudes towards people living with HIV/AIDS and their overall views on ARV. Secondary data were collected from published and unpublished sources. ARV registers and records acted as the principal source of secondary data. They were used to ascertain the people who were HIV-positive and on ARVs. These records were collected from the MOH in Gaborone and the Thamaga Hospital and clinics in the surrounding villages. <xref rid="T0001" ref-type="table">Table 1</xref> is a summary of the objectives, research questions and methods used in the data collection.
<table-wrap id="T0001" orientation="portrait" position="float"><label>Table 1. </label><caption><title>Summary of objectives, research questions and methods of data collection and analysis.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left">Objectives</th><th align="center">Research questions</th><th align="center">Methods of data collection</th><th align="center">Tools of data analysis</th></tr></thead><tbody><tr><td rowspan="2" align="left">1. To examine the extent of ARV uptake in these villages</td><td rowspan="2" align="left">How do age and gender influence ARV uptake among the infected?</td><td align="left">Tracking people on ARV with aid of health workers</td><td rowspan="2" align="left">Use of SPSS, Bar graphs, Microsoft Excel. Listing responses from survey data</td></tr><tr><td align="left">• 95% significance level established</td></tr><tr><td align="left">2. To find out the socio-economic factors which inhibit or constrain ARV uptake in these villages</td><td align="left">How do public attitudes, culture, religion, lack of dialogue between parents and children and residence or distance affect the uptake of ARV in Thamaga and surrounding villages?</td><td align="left">Use of questionnaires and interviews (with the residents or the public, key informants and people on ARV)</td><td align="left">Description: listing responses from survey data. Use of Frequencies, SPSS and Bar graphs</td></tr></tbody></table></table-wrap></p><p>Data were gathered, using open-ended and closed questions. Also, before conducting the main interviews, a pilot study was also carried out in order to test the accuracy of the questionnaires. The two primary investigators did the self-administration of questionnaires with no external assistants.</p></sec><sec id="S004-S2002-S3004"><title>Key informants</title><p>People on ARV were central to this study and to track them key informants were indispensable. Key informants (16) were drawn mainly from health workers and doctors in the Thamaga Hospital and village clinics in the surrounding areas. Other key informants (4) of the study included officials from the MOH in Gaborone and NGOs such as United Nations Agency on AIDS, National AIDS Coordination Agency and ACHAP. These key informants were chosen because the researchers believed them to be knowledgeable on the issues being investigated. The health workers (12) were of particular assistance in tracking down the people when they came for their ARVs in the hospital and clinics.</p></sec></sec><sec id="S004-S2003"><title>Data management and data analysis</title><p>The data were coded, keyed and descriptively analysed through Statistical Package of Social Sciences (SPSS) and Microsoft Excel. Descriptive methods of statistical analysis were used, as indicated already. The findings were presented in the form of cross-tabulations, tables and pie charts.</p></sec></sec><sec id="S005"><title>Findings</title><sec id="S005-S2001"><title>Extent of ARV uptake</title><p><xref rid="T0002" ref-type="table">Table 2</xref> shows the age and sex distribution of people on ARV in Thamaga and surrounding villages. From the table, we can observe that females of all ages were dominant.
<table-wrap id="T0002" orientation="portrait" position="float"><label>Table 2. </label><caption><title>Age and sex distribution of patients on ARVs in Thamaga and surrounding villages, 2009.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left">Age range (years)</th><th align="center">Females at Thamaga hospital</th><th align="center">Females in surrounding clinics</th><th align="center">Males in Thamaga hospital</th><th align="center">Males in surrounding clinics</th><th align="center">Total</th><th align="center">Percentage</th></tr></thead><tbody><tr><td align="left">0–4</td><td align="char" char=".">17</td><td align="char" char=".">6</td><td align="char" char=".">15</td><td align="char" char=".">2</td><td align="char" char=".">40</td><td align="char" char=".">1.12</td></tr><tr><td align="left">5–9</td><td align="char" char=".">17</td><td align="char" char=".">0</td><td align="char" char=".">19</td><td align="char" char=".">2</td><td align="char" char=".">38</td><td align="char" char=".">1.06</td></tr><tr><td align="left">10–14</td><td align="char" char=".">15</td><td align="char" char=".">5</td><td align="char" char=".">15</td><td align="char" char=".">1</td><td align="char" char=".">36</td><td align="char" char=".">1.01</td></tr><tr><td align="left">15–19</td><td align="char" char=".">4</td><td align="char" char=".">11</td><td align="char" char=".">7</td><td align="char" char=".">3</td><td align="char" char=".">25</td><td align="char" char=".">0.70</td></tr><tr><td align="left">20–24</td><td align="char" char=".">21</td><td align="char" char=".">101</td><td align="char" char=".">2</td><td align="char" char=".">15</td><td align="char" char=".">139</td><td align="char" char=".">3.89</td></tr><tr><td align="left">25–29</td><td align="char" char=".">101</td><td align="char" char=".">273</td><td align="char" char=".">23</td><td align="char" char=".">77</td><td align="char" char=".">474</td><td align="char" char=".">13.27</td></tr><tr><td align="left">30–34</td><td align="char" char=".">164</td><td align="char" char=".">325</td><td align="char" char=".">84</td><td align="char" char=".">179</td><td align="char" char=".">752</td><td align="char" char=".">21.05</td></tr><tr><td align="left">35–39</td><td align="char" char=".">146</td><td align="char" char=".">199</td><td align="char" char=".">127</td><td align="char" char=".">191</td><td align="char" char=".">663</td><td align="char" char=".">18.56</td></tr><tr><td align="left">40–44</td><td align="char" char=".">116</td><td align="char" char=".">126</td><td align="char" char=".">96</td><td align="char" char=".">132</td><td align="char" char=".">470</td><td align="char" char=".">13.16</td></tr><tr><td align="left">45–49</td><td align="char" char=".">87</td><td align="char" char=".">80</td><td align="char" char=".">86</td><td align="char" char=".">107</td><td align="char" char=".">360</td><td align="char" char=".">10.08</td></tr><tr><td align="left">50–54</td><td align="char" char=".">61</td><td align="char" char=".">45</td><td align="char" char=".">89</td><td align="char" char=".">55</td><td align="char" char=".">250</td><td align="char" char=".">7</td></tr><tr><td align="left">55–59</td><td align="char" char=".">30</td><td align="char" char=".">27</td><td align="char" char=".">55</td><td align="char" char=".">36</td><td align="char" char=".">148</td><td align="char" char=".">4.14</td></tr><tr><td align="left">60+</td><td align="char" char=".">45</td><td align="char" char=".">33</td><td align="char" char=".">45</td><td align="char" char=".">46</td><td align="char" char=".">169</td><td align="char" char=".">4.73</td></tr><tr><td align="left">Age unknown</td><td align="char" char=".">2</td><td align="char" char=".">2</td><td align="char" char=".">2</td><td align="char" char=".">2</td><td align="char" char=".">8</td><td align="char" char=".">0.22</td></tr><tr><td align="left">Total</td><td align="char" char=".">826</td><td align="char" char=".">1233</td><td align="char" char=".">665</td><td align="char" char=".">848</td><td align="char" char=".">3572</td><td align="char" char=".">100</td></tr></tbody></table><table-wrap-foot><p>Source: MOH (<xref rid="CIT0012" ref-type="bibr">2009</xref>).</p></table-wrap-foot></table-wrap></p><p>People in the age group of 25 and above showed a high percentage of people on ARVs. The age groups with the highest percentages were 30–34 and 35–39 with respectively 21.05% and 18.56%. <xref rid="T0003" ref-type="table">Table 3</xref> shows the recorded number of people collecting their ARV from clinics in the study villages in 2010. Mmankgodi clinic recorded the lowest number of patients, while Nkoyaphiri had the highest number of patients. This could be due to the fact that Nkoyaphiri is nearer to Mogoditshane, a densely populated surburb of Gaborone, the national capital. Most patients who live in Gaborone and its suburbs who might be afraid to go for therapy in the city where people know them might go to clinics far away such as Nkoyaphiri.
<table-wrap id="T0003" orientation="portrait" position="float"><label>Table 3. </label><caption><title>Number of people collecting ARVs from clinics in the study villages in 2010.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left">ARV site</th><th align="center">Total number of patients</th></tr></thead><tbody><tr><td align="left">Thamaga primary hospital</td><td align="char" char=".">1646</td></tr><tr><td align="left">Nkoyaphiri clinic</td><td align="char" char=".">1726</td></tr><tr><td align="left">Gabane clinic</td><td align="char" char=".">392</td></tr><tr><td align="left">Thamaga clinic</td><td align="char" char=".">114</td></tr><tr><td align="left">Mmankgodi clinic</td><td align="char" char=".">70</td></tr><tr><td align="left">Kopong clinic</td><td align="char" char=".">200</td></tr><tr><td align="left">Mmopane clinic</td><td align="char" char=".">120</td></tr><tr><td align="left">Total</td><td align="char" char=".">4268</td></tr></tbody></table><table-wrap-foot><p>Source: MOH (<xref rid="CIT0013" ref-type="bibr">2010</xref>).</p></table-wrap-foot></table-wrap></p></sec><sec id="S005-S2002"><title>Constraints to ARV uptake</title><p>As noted, the theory of reasoned action says that a person's behaviour is determined by, among other things, the opinions of the person's social environment (Azjen & Fishbein <xref rid="CIT0001" ref-type="bibr">1980</xref>). Different people would always react differently. One of the social factors assumed to inhibit ARV uptake was public attitude and to verify this, respondents from the general public were asked how they would treat people with HIV who were on ARVs (<xref rid="T0004" ref-type="table">Table 4</xref>).
<table-wrap id="T0004" orientation="portrait" position="float"><label>Table 4. </label><caption><title>How would you treat someone who is taking ARVs?</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left"> </th><th align="center">Frequency</th><th align="center">Percent</th><th align="center">Cumulative per cent</th></tr></thead><tbody><tr><td align="left">With love and respect</td><td align="char" char=".">68</td><td align="char" char=".">46.9</td><td align="char" char=".">46.9</td></tr><tr><td align="left">Do not want anything to do with them</td><td align="char" char=".">11</td><td align="char" char=".">7.6</td><td align="char" char=".">7.6</td></tr><tr><td align="left">Treat like any other person</td><td align="char" char=".">66</td><td align="char" char=".">45.5</td><td align="char" char=".">45.5</td></tr><tr><td align="left">Total</td><td align="char" char=".">145</td><td align="char" char=".">100.0</td><td align="char" char=".">100.0</td></tr></tbody></table></table-wrap></p><p>The results showed that 46.9% respondents would not shun them and would treat them with love and respect. About 45.5% indicated that they would not discriminate against people on ARVs, while 7.6% indicated that they would not want to have anything to do with them as they were sick. The evidence pointed to villagers gradually starting to realize that HIV/AIDS is like any other disease. ‘These people are like any other people, who are we to judge others?' said one respondent. Another respondent from survey said ‘HIV positive persons are sinful people. They go around sleeping with everyone and the next thing they want is mercy from us. No! They should live in their own world'.</p><p>Religion is another socio-cultural factor that plays an important role in the lives of villagers whose influence on ARV uptake was investigated. <xref rid="T0005" ref-type="table">Table 5</xref> shows religion and its effects on ARV uptake. There were a large number of respondents (55.9%) who attended churches that encouraged the use of ARVs. About 12% went to churches that discouraged the use of ARVs, while 11% went to churches that did not discuss about the use of ARVs. Out of the total sample of 145, 0.7% said that their religion (Catholic) allowed ARVs but emphasized abstinence; another 0.7% said that their religion encouraged the use of ARVs and traditional medicines. About 13% did not belong to any religious denomination and therefore had no views to express on the influence of religion on ARV uptake. The results were further evaluated to see if there is a statistical difference in how the respondents from religions that encouraged and discouraged the use of ARVs would treat people who were on ARVs. Chi-square (<italic>χ</italic><sup>2</sup>) was used since the variables were categorical. In testing this relationship, a positive association was found (<italic>χ</italic><sup>2</sup> = 118.045, df = 2, Phi = 0.902 <italic>P</italic> > 0.01). Most of the respondents said that they would treat HIV people with love and respect. The majority of those respondents (57%) who said that they would treat HIV patients with love and respect went to churches that encouraged the use of ARVs, while only 2% went to churches that do not (<xref rid="T0006" ref-type="table">Table 6</xref>). Respondents who were members of churches that discouraged the use of ARVs were mostly the Zezurus who believed that God is the creator and the healer. With this belief, they do not even take their sick relatives to the clinics when they are ill. This discourages the government's efforts of trying to bring facilities closer to people. Since churches like the Catholics encourage the use of ARVs, but emphasize abstinence, if a member of the church had sex outside marriage and contracted the disease, they would invariably hide it from other church members because of the fear of being judged. Most Batswana still believe that traditional doctors can cure HIV/AIDS. So, they sometimes stop the treatment and take on traditional herbs. This evidence was corroborated by key informants, who said that some villagers preferred the use of traditional medicine while others used traditional medicine while on ARVs which was a health risk.
<table-wrap id="T0005" orientation="portrait" position="float"><label>Table 5. </label><caption><title>Effect of religion on ARV.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left"> </th><th align="center">Per cent</th><th align="center">Cum. per cent</th></tr></thead><tbody><tr><td align="left">Encourage ARVs</td><td align="char" char=".">81</td><td align="char" char=".">55.9</td></tr><tr><td align="left">Do no talk about them</td><td align="char" char=".">16</td><td align="char" char=".">11.0</td></tr><tr><td align="left">Do not know</td><td align="char" char=".">9</td><td align="char" char=".">6.2</td></tr><tr><td align="left">Discourage them</td><td align="char" char=".">18</td><td align="char" char=".">12.4</td></tr><tr><td align="left">Partnership between tradition and modern medicine</td><td align="char" char=".">1</td><td align="char" char=".">0.7</td></tr><tr><td align="left">Not applicable</td><td align="char" char=".">19</td><td align="char" char=".">13.1</td></tr><tr><td align="left">Allowed but abstinence emphasized</td><td align="char" char=".">1</td><td align="char" char=".">0.7</td></tr><tr><td align="left">Total</td><td align="char" char=".">145</td><td align="char" char=".">100.0</td></tr></tbody></table></table-wrap><table-wrap id="T0006" orientation="portrait" position="float"><label>Table 6. </label><caption><title>Effects of religion on ARV uptake.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th colspan="3" align="left"> </th><th align="center">How the residents treat people taking ARV treatment</th><th align="center">How the residents treat people taking ARV treatment</th><th align="center">Total</th></tr><tr><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center">Treat with love, and no discrimination</th><th align="center">Would not associate with patients on ARVs</th><th align="center"> </th></tr></thead><tbody><tr><td rowspan="3" align="left">Religion effects on ARV use</td><td rowspan="3" align="left">Encourage the use of ARVs</td><td align="left">Count</td><td align="left">82</td><td align="left">0</td><td align="left">82</td></tr><tr><td align="left">% within religion effects on ARV use</td><td align="left">100.0%</td><td align="left">0.0%</td><td align="left">100.0%</td></tr><tr><td align="left">% of total</td><td align="left">56.6%</td><td align="left">0.0%</td><td align="left">56.6%</td></tr><tr><td rowspan="3" align="left"> </td><td rowspan="3" align="left">Do not discuss the use of ARVs</td><td align="left">Count</td><td align="left">45%</td><td align="left">0</td><td align="left">45</td></tr><tr><td align="left">% within religion effects on ARV use</td><td align="left">100.0%</td><td align="left">0.0%</td><td align="left">100.0%</td></tr><tr><td align="left">% of total</td><td align="left">31.0%</td><td align="left">0.0%</td><td align="left">31.0%</td></tr><tr><td rowspan="3" align="left"> </td><td rowspan="3" align="left">Discourage the use of ARVs</td><td align="left">Count</td><td align="left">3</td><td align="left">15</td><td align="left">18%</td></tr><tr><td align="left">% within religion effects on ARV use</td><td align="left">16.7%</td><td align="left">83.3%</td><td align="left">100.0%</td></tr><tr><td align="left">% of total</td><td align="left">2.1%</td><td align="left">10.3%</td><td align="left">12.4%</td></tr><tr><td rowspan="3" align="left">Total</td><td rowspan="3" align="left"> </td><td align="left">Count</td><td align="left">130</td><td align="left">15</td><td align="left">145</td></tr><tr><td align="left">% within religion effects on ARV use</td><td align="left">89.7%</td><td align="left">10.3%</td><td align="left">100.0%</td></tr><tr><td align="left">% of total</td><td align="left">89.7%</td><td align="left">10.3%</td><td align="left">100.0%</td></tr></tbody></table></table-wrap></p><p>Parent–children dialogue was another social factor identified as inluencing ARV uptake. Respondents were asked whether parents had dialogue with their chidren on ARV uptake. About 46% said that parents talked to their children about ARV issues (<xref rid="F0003" ref-type="fig">Fig. 3</xref>). Of the total sample, 54% said that their parents never discussed ARV issues with them. In Setswana culture, communication between parents and children about sexual behavior is not common. This leads to children making mistakes because there is no one to guide them. Parents believed that teachers were doing their job at school when teaching their kids about sexual reproduction. This was what a 15-year-old respondent had to say, ‘my mother would chase me out of the house if I metioned AIDS and ARVs' (respondent from survey data).
<fig id="F0003" orientation="portrait" position="float"><label>Fig. 3. </label><caption><p>Parental dialogue on HIV/AIDS, ARV issues.</p></caption><graphic xlink:href="rsah-11-167-g003"></graphic></fig></p><p>During the survey, the practice of breastfeeding was one of the factors identified by key informants from the MOH as influencing and being influenced by ARV uptake. Breastfeeding is one of the significant cultural practices in Botswana and according to the key informants, many mothers feel that a woman who does not breastfeed might not be accepted in the society. Often, if a mother did not breastfeed her child, people tended to suspect that she was HIV-positive and they sometimes stigmatized and called her funny names. Because of this, some HIV patients ended up breastfeeding in order to fit into the social setup.</p></sec><sec id="S005-S2003"><title>The 61 case study patients</title><p>As already stated, patients on ARV were central to this study and 61 of them were purposively selected to get in-depth information on the disease and patients' experience and constraints of ARV uptake. <xref rid="F0004" ref-type="fig">Fig. 4</xref> illustrates the ages of the case study patients. The majority of the patients were aged 40–49 (41%). Those in the ages 30–39 followed at 33%. Patients aged 15–29 and 50–59 each had 11%. Those with the least percentage were the patients aged 60+. Females constituted 59% of the sample and males 41%.
<fig id="F0004" orientation="portrait" position="float"><label>Fig. 4. </label><caption><p>Age of case study HIV patients.</p></caption><graphic xlink:href="rsah-11-167-g004"></graphic></fig></p><p>To ascertain whether there were any social inhibitions that would prevent clients from going for ARV treatment, patients were asked whether they were free to go for ARV treatment.</p><p><xref rid="F0005" ref-type="fig">Fig. 5</xref> shows patients' responses.
<fig id="F0005" orientation="portrait" position="float"><label>Fig. 5. </label><caption><p>People living with HIV and on ARV.</p></caption><graphic xlink:href="rsah-11-167-g005"></graphic></fig></p><p>Of the 61 respondents, 66.4% said that they were free to go for their medication, while only 33.6% said that they were not free. The reason the latter gave for not being free was that people shunned them because they were infected. People said that they were just waiting to die. This attitude made it difficult for them to go freely for their medication. Most of the people who said they were free to go for their medication explained that it was because they had accepted their status.</p><p>Those patients who felt that they were not free to go for AIDS medication said that it was because of the fear of stigmatization and discrimination from society. Another factor mentioned was lack of cooperation from employers who frequently refused to give permission or allow sick leave to the people. Most of the people who were free were those with full-blown AIDS and such people were free because they did not want to die and therefore did not care about what people thought about them. Several of the people on ARV came to Thamaga hospital from places as far as Moshupa, Lobatse, Nkoyaphiri, Gakgatla, Manyana and Kumakwane for collection of their medication and treatment.</p><p>During the study, clients on ARV were asked if they had made known that they were on ARV with any one. This was asked to ascertain whether clients were free and open to discuss the subject of HIV and ARV. The study found that 88% of the patients discussed their sero and ARV status with their parents or very close relatives. Another 86% discussed their status with their spouses. About 5% said that they never discussed with any one about their HIV sero status. These findings show that the patients limited the discussion to close family members and spouses and not to other members of society.</p><p>The patients were also asked to share the perceptions or reactions of the people to whom they disclosed the fact that they were on ARV. One female patient revealed that when she broached her ARV status to her spouse, he started neglecting her and eventually dumped her for another woman. Another young patient said that he discussed the results wih his siblings and they started calling him all sorts of names and even tried to shun him. The clients who did not discuss their sero and ARV status with anyone pointed out that the main reason was fear or stigma and discrimination.</p><p>According to the patients, especially public attitude had continued to be a major problem as they were often shunned by some members of the public who happened to know that they were on ARV. Most often, people stigmatized and discriminated against them. However, according to the patients, the perceptions of parents regarding treatment were generally positive as parents were supportive and encouraged them to take the treatment seriously. The study noted that there were mixed perceptions and attitudes between spouses who were informed about ARV treatment. Some spouses were supportive, but others, uncooperative. One husband chased the wife out of their matrimonial home when he was told about his spouse's ARV treatment. The study found that a primary concern before patients started ARV treatment was fear of the consequeces. Many thought that they would die and several were worried about possible side effects.</p><p>Finally, distance was one of the factors identified by patients as inhibiting ARV uptake (<xref rid="T0007" ref-type="table">Table 7</xref>). This factor is important when viewed within the context of patients' affordability of transport costs and/or ability to travel on foot to collect medication.
<table-wrap id="T0007" orientation="portrait" position="float"><label>Table 7. </label><caption><title>Distance travelled by HIV patients to ARV clinics.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th align="left">Distance</th><th align="center">Frequency</th><th align="center">Percent</th></tr></thead><tbody><tr><td align="left">0–0.5 km</td><td align="left">32</td><td align="left">51.9</td></tr><tr><td align="left">1–10 km</td><td align="left">11</td><td align="left">18.5</td></tr><tr><td align="left">More than 10 km</td><td align="left">18</td><td align="left">29.6</td></tr><tr><td align="left">Total</td><td align="left">61</td><td align="left">100.0</td></tr></tbody></table></table-wrap></p><p>On this aspect, patients were asked about the distance they travelled to obtain their dosages of ARV. About 52% travelled 0–0.5 kms from their places of residence to get their medication, 18.5% travelled 1–10 kms and 29.6%, more than 10 kms. Those staying far from ARV sites included illiterates and poverty-stricken people, who besides being ill-informed, often defaulted. ANOVA was used to test the variances between the distances travelled by the patients (<xref rid="T0008" ref-type="table">Table 8</xref>). Because of poverty and unemployment, some HIV patients walked long distances to collect their ARVs. While some patients walked distances of less than 5 kms for ARVs, some walked more than 10 kms for ARVs (F4.224, df (1, 59) <italic>P</italic> > 0.05). For people who are sick, distance travelled to collect ARVs becomes a critical variable.
<table-wrap id="T0008" orientation="portrait" position="float"><label>Table 8. </label><caption><title>ANOVA on distance travelled by patients.</title></caption><pmc-comment>OASIS TABLE HERE</pmc-comment><table frame="hsides" rules="groups"><colgroup><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col><col width="1*"></col></colgroup><thead valign="bottom"><tr><th colspan="3" align="left"> </th><th align="center">Sum of squares</th><th align="center">df</th><th align="center">Mean square</th><th align="center"><italic>F</italic></th><th align="center">Sig.</th></tr></thead><tbody><tr><td align="left">Between groups</td><td align="left">Combined</td><td align="left">Unweighted</td><td align="left">3.126</td><td align="left">1</td><td align="left">3.126</td><td align="left">4.224</td><td align="left">0.044</td></tr><tr><td colspan="3" align="left"> </td><td align="left">3.126</td><td align="left">1</td><td align="left">3.126</td><td align="left">4.224</td><td align="left">0.044</td></tr><tr><td colspan="3" align="left"> </td><td align="left">3.126</td><td align="left">1</td><td align="left">3.126</td><td align="left">4.224</td><td align="left">0.044</td></tr><tr><td colspan="3" align="left">Within groups</td><td align="left">43.661</td><td align="left">59</td><td align="left">0.740</td><td align="left"> </td><td align="left"> </td></tr><tr><td colspan="3" align="left">Total</td><td align="left">46.787</td><td align="left">60</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr></tbody></table></table-wrap></p><p>About 48% of the patients indicated that travel posed a constraint. They associated long travel with high transport costs and said that they sometimes failed to go to collect their medication because they could not afford the transport costs. The study found that about 15% of the pateints walked on foot from their villages to the health facilities since they could not afford the cost of travel by bus or taxi. Travel therefore posed a big challenge in accessing ART in the rural areas, especially when patients had no money and were sick or weak to easily move about.</p><p>To sum up, in view of the foregoing constraints, many of the patients did not feel really free to go for ARVs and were finding life difficult to cope. It would appear that, of all the constraints, public attitude towards HIV patients on ARV, fear, stigmatization and discrimination, parental dialogue, religion. distance and transport affordability were the most important factors constraining ARV uptake.</p></sec></sec><sec id="S006"><title>Discussion, summary and conclusion</title><p>The study has shown that females on ARV were showing high numbers than males in the villages. This finding corroborates two studies, one from Tanzania and the other from Malawi, which respectively found that 69% and 64% of people on ART were women (Dennis <italic>et al</italic>. <xref rid="CIT0003" ref-type="bibr">2007</xref>; Vilili <xref rid="CIT0022" ref-type="bibr">2008</xref>). This could partially be that many females in the villages were involved in health-related matters and often made a follow-up when they fell sick, whereas males mostly kept their illnesses to themselves. Some of the people living with HIV believed that ARV therapy could better their lives during the initial stages of introduction, but with time, they lost hope and discontinued the treatment. In a study on the progression from acquiring AIDS and until death in Botswana, it was found that 85% of the people who received ART survived in the first year and 95% survived each subsequent year (Stover, Dayton & Gabriel <xref rid="CIT0019" ref-type="bibr">2008</xref>). It was noted that first-year survival was lower than in subsequent years since some people started ART too late and died before it had a chance to restore their immune system function. This could explain the reluctance of some people on ARV in the study area because they started the treatment late.</p><p>It was also found that it was generally not the practice for parents in the study villages to communicate AIDS and ARV issues with their children. In Setswana culture, communication between parents and children about sexual behaviour is not common. This leads to children making mistakes because there is no one to guide them at home on sexual behaviour. Some of the people living with HIV were working and their workplaces did not have ARV drugs and they sometimes needed to miss work in order to refill. Some employers refused to permit their employees to go on leave; this led to some patients on ARVs defaulting on treatment. It was found that there were religions in the area which discouraged the use of ARV. The spiritual leaders of some of these religions made their followers believe that God was the only healer. There were also traditional doctors who made their patients mix traditional herbs with ARV treatment and cultural practices in infant feeding which affected ARV uptake in the study area. Generally, women who were on ARV were not advised to breastfeed if they were not on PMTCT. Breastfeeding is important in Setswana culture, and as noted, if a mother did not breastfeed her child, she was stigmatized and called all kinds of names (MOH <xref rid="CIT0011" ref-type="bibr">2008</xref>).</p><p>Even though ARV uptake had constraints at the village level, efforts were being made to overcome some of them. It was observed that nurses, doctors and chiefs taught people normally at kgotlas in the villages about the dangers of the epidemic and how to use ARV. The villagers including patients on ARV were also provided with free HIV testing and condoms in order to promote change in behaviours. The MOH provided information to the public using its strategy known as IEC. This involved giving people pamphlets such as <italic>20 Most Asked Questions</italic>, flyers on the importance of ARVs and interactive Community Mobilization Tool kits. In collaboration with ACHAP, the MOH had provided IDC Clinics which were attached to village hospitals and clinics. In the study area, three of the villages, Thamaga, Kumakwane and Mankgodi, were provided with such facilities.These facilities were well equipped with both human resources and ARV drugs which were dispensed freely to patients.</p><p>Encouraging progress has been made with providing facilities and remedies for people on ARV in the study villages. The main driving force behind the progress being made was the government's Masa ARV programme which provided free treatment and support given to the programme by NGOs such as ACHAP. In spite of the constraints outlined above, the outlook for ARV uptake looks generally promising for the future.</p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thank Dr Meleckidzedeck Khayesi of the World Health Organization (WHO), Mr Bernard Amahaya Kadasia of the International AIDS Society and the two anonymous referees for their helpful comments on the original draft. We also thank ProfessorT Kitene-Ngoy of the French Department of the University of Botswana for providing a French translation of the Abstract, and Mr Peace Koorutwe for drawing <xref rid="F0001" ref-type="fig">Fig. 1</xref>.</p></ack><ref-list><title>References</title><ref id="CIT0001"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Azjen</surname><given-names>L.</given-names></name><name><surname>Fishbein</surname><given-names>M.</given-names></name></person-group><year>1980</year><source>Understanding Attitudes and Predicting Social Behavior</source><publisher-loc><named-content content-type="city">Englewood-Cliffs</named-content>, <named-content content-type="state">NJ</named-content></publisher-loc><publisher-name>Prentice-Hall</publisher-name></element-citation></ref><ref id="CIT0002"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Creswell</surname><given-names>J. W.</given-names></name></person-group><year>1994</year><source>Research Design: Qualitative and Quantitative Approaches</source><publisher-loc><named-content content-type="city">London</named-content></publisher-loc><publisher-name>Sage Publications</publisher-name></element-citation></ref><ref id="CIT0003"><element-citation publication-type="standard"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>K.</given-names></name><name><surname>Wasai</surname><given-names>L.</given-names></name><name><surname>Ellen</surname><given-names>S.</given-names></name></person-group><year>2007</year><comment>Free ARV Programme in Tanzania: The Teething Challenges. <ext-link ext-link-type="uri" xlink:href="http://www.accordinternational.org">http://www.accordinternational.org</ext-link> (Accessed 10 October 2010</comment></element-citation></ref><ref id="CIT0004"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gatrell</surname><given-names>A. C.</given-names></name></person-group><year>2002</year><source>An Introduction to Geographies of Health</source><publisher-loc><named-content content-type="city">Oxford</named-content></publisher-loc><publisher-name>Blackwell Publications Limited</publisher-name></element-citation></ref><ref id="CIT0005"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gatrell</surname><given-names>A. C.</given-names></name><name><surname>Elliott</surname><given-names>S. J.</given-names></name></person-group><year>2009</year><source>Geographies of Health: AN Introduction</source><edition>Second Edition</edition><publisher-loc><named-content content-type="city">Chichester</named-content></publisher-loc><publisher-name>Wiley-Blackwell</publisher-name></element-citation></ref><ref id="CIT0006"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Government of Botswana.</collab></person-group><year>2006</year><source>Masa Antiretroviral Therapy</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Ministry of Health</publisher-name></element-citation></ref><ref id="CIT0007"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S. P.</given-names></name></person-group><year>2012</year><article-title>Mind the Gap: Access to ARV Medication, Rights and the Politics of Scale in South Africa</article-title><source>Social Science & Medicine</source><volume>74</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2010.11.005</pub-id><pub-id pub-id-type="pmid">21146274</pub-id></element-citation></ref><ref id="CIT0008"><element-citation publication-type="standard"><person-group person-group-type="author"><name><surname>Libeon</surname><given-names>C.</given-names></name></person-group><year>2007</year><comment>Challenges of ART Treatment in Tanzania. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/medicine">www.who.int/medicine</ext-link> (Accessed 10 October 2010</comment></element-citation></ref><ref id="CIT0009"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health.</collab></person-group><year>2004</year><source>Preliminary Botswana HIV/AIDS II Impact Survey (BAIS</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Central Statistics Office</publisher-name></element-citation></ref><ref id="CIT0010"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health.</collab></person-group><year>2005</year><source>A Chronicle of ARV Therapy Information Education and Communication in Botswana</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Government of Botswana</publisher-name></element-citation></ref><ref id="CIT0011"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health.</collab></person-group><year>2008</year><source>Preliminary Botswana HIV/AIDS III Impact Survey (BAIS</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Central Statistics Office</publisher-name></element-citation></ref><ref id="CIT0012"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health.</collab></person-group><year>2009</year><source>Thamaga Primary Hospital Medical Records</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Ministry of Health</publisher-name></element-citation></ref><ref id="CIT0013"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health.</collab></person-group><year>2010</year><source>HAART Patient Update Summary</source><publisher-loc><named-content content-type="city">Gaborone</named-content></publisher-loc><publisher-name>Ministry of Health</publisher-name></element-citation></ref><ref id="CIT0014"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosarwe</surname><given-names>Q.</given-names></name></person-group><year>2014</year><article-title>Almost 70% of Men on Seoaration HIV Infected – Survey</article-title><source>The Botswana Gazette</source><comment>15 January, 7</comment></element-citation></ref><ref id="CIT0015"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>L. S.</given-names></name><name><surname>Fielding</surname><given-names>K.</given-names></name><name><surname>Avalos</surname><given-names>A.</given-names></name><name><surname>Dickinson</surname><given-names>D.</given-names></name><name><surname>Gaolathe</surname><given-names>T.</given-names></name><name><surname>Geisler</surname><given-names>P. W.</given-names></name></person-group><year>2008</year><article-title>The Relationship of Acceptance or Denial of HIV-Status to Antiretroviral Adherence among Adult HIV Patients in Urban Botswana</article-title><source>Social Science and Medicine</source><volume>67</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2008.03.042</pub-id><pub-id pub-id-type="pmid">18455285</pub-id></element-citation></ref><ref id="CIT0016"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntata</surname><given-names>P. R. T.</given-names></name></person-group><year>2007</year><article-title>Equity in Access to ARV Drugs in Malawi</article-title><source>Journal of Social Aspects of HIV/AIDS</source><volume>2</volume><fpage>71</fpage><lpage>91</lpage></element-citation></ref><ref id="CIT0017"><element-citation publication-type="standard"><person-group person-group-type="author"><collab>ONE International.</collab></person-group><year>2011</year><comment>Worldwide HIV Facts: Treatment, Prevention and Care. <ext-link ext-link-type="uri" xlink:href="http://www.one.org/HIV-AIDS">www.one.org/HIV-AIDS</ext-link> (Accessed 18 July 2011</comment></element-citation></ref><ref id="CIT0018"><element-citation publication-type="standard"><person-group person-group-type="author"><name><surname>Seleke</surname><given-names>S. F.</given-names></name></person-group><year>2008</year><comment>Challenges on ARV in Botswana. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/botusa/news/docs/BOTUSA">www.cdc.gov/botusa/news/docs/BOTUSA</ext-link> (Accessed 10 October 2010</comment></element-citation></ref><ref id="CIT0019"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stover</surname><given-names>A. S.</given-names></name><name><surname>Dayton</surname><given-names>D. F.</given-names></name><name><surname>Gabriel</surname><given-names>S.</given-names></name></person-group><year>2008</year><source>AIDS Module of Spectrum</source><publisher-loc><named-content content-type="city">New York</named-content></publisher-loc><publisher-name>M.E Sharpe Publications</publisher-name></element-citation></ref><ref id="CIT0020"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>B. S.</given-names></name><name><surname>Garduno</surname><given-names>S. L.</given-names></name><name><surname>Reyes</surname><given-names>E. V.</given-names></name><name><surname>Rojas</surname><given-names>Y.</given-names></name><name><surname>Valiño</surname><given-names>R.</given-names></name><name><surname>Donastorg</surname><given-names>K.</given-names></name><etal><italic>et al.</italic></etal></person-group><year>2011</year><article-title>HIV Care for Geographically Mobile Populations</article-title><source>Mt Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine</source><volume>78</volume><fpage>342</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1002/msj.20255</pub-id></element-citation></ref><ref id="CIT0021"><element-citation publication-type="book"><person-group person-group-type="author"><collab>United Nations Development Programme [UNDP].</collab></person-group><year>1997</year><source>Reconceptualising Governance, Division of Public Affairs</source><publisher-loc><named-content content-type="city">New York</named-content></publisher-loc><publisher-name>UNDP</publisher-name></element-citation></ref><ref id="CIT0022"><element-citation publication-type="standard"><person-group person-group-type="author"><name><surname>Vilili</surname><given-names>G. L.</given-names></name></person-group><year>2008</year><comment>Geographical Analysis of Antiretroviral Uptake among the Youth in Lilongwe Rural and Urban Central Malawi. Unpublished Thesis. Geography Studies: University of Malawi</comment></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002C56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.32. |  |